Medpace Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Medpace Holdings, Inc. (MEDP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 93.08 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-07-23
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 92.88K shares, a 1164.71% increase year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 200.00 shares, a 99.83% decline year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 487.00 shares.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 127.76K shares, a 57.36% increase from fiscal 2024.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 81.19K shares, a 552.83% increase from fiscal 2023.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 12.44K shares, a 95.07% decline from fiscal 2022.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 252.49K shares, a 10.65% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 92.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | 93.08K shares 10-Q · filed 2026-07-23 | 93.57K shares derived: sum of 3 quarters · filed 2026-07-23 | 93.57K shares derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | 200.00 shares 10-Q · filed 2026-04-23 | 687.00 shares derived: sum of 2 quarters · filed 2026-04-23 | 687.00 shares derived: sum of 3 quarters · filed 2026-04-23 | 8.03K shares derived: sum of 4 quarters · filed 2026-04-23 |
| 2025-12-31 | 487.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | 487.00 shares derived: sum of 2 quarters · filed 2026-02-10 | 7.83K shares derived: sum of 3 quarters · filed 2026-02-10 | 127.76K shares 10-K · filed 2026-02-10 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | 7.34K shares derived: sum of 2 quarters · filed 2025-10-23 | 127.28K shares 10-Q · filed 2025-10-23 | 127.28K shares derived: sum of 4 quarters · filed 2026-02-10 |
| 2025-06-30 | 7.34K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | 127.28K shares 10-Q · filed 2025-07-22 | 127.28K shares derived: sum of 3 quarters · filed 2026-02-10 | 202.75K shares derived: sum of 4 quarters · filed 2026-02-10 |
| 2025-03-31 | 119.93K shares 10-Q · filed 2025-04-22 | 119.93K shares derived: sum of 2 quarters · filed 2026-02-10 | 195.41K shares derived: sum of 3 quarters · filed 2026-02-10 | 201.13K shares derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | 75.47K shares derived: sum of 2 quarters · filed 2026-02-10 | 81.19K shares derived: sum of 3 quarters · filed 2026-02-10 | 81.19K shares 10-K · filed 2026-02-10 |
| 2024-09-30 | 75.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | 81.19K shares derived: sum of 2 quarters · filed 2024-10-22 | 81.19K shares 10-Q · filed 2024-10-22 | 81.19K shares derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | 5.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-23 | 5.72K shares 10-Q · filed 2024-07-23 | 5.72K shares derived: sum of 3 quarters · filed 2026-02-10 | 5.72K shares derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-04-23 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-10 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-10 | 10.61K shares derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-10 | 10.61K shares derived: sum of 3 quarters · filed 2026-02-10 | 12.44K shares 10-K · filed 2026-02-10 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-24 | 10.61K shares derived: sum of 2 quarters · filed 2023-10-24 | 12.44K shares 10-Q · filed 2023-10-24 | 12.44K shares derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | 10.61K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | 12.44K shares 10-Q · filed 2023-07-25 | 12.44K shares derived: sum of 3 quarters · filed 2025-02-11 | 13.27K shares derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | 1.82K shares 10-Q · filed 2023-04-25 | 1.82K shares derived: sum of 2 quarters · filed 2025-02-11 | 2.65K shares derived: sum of 3 quarters · filed 2025-02-11 | 14.07K shares derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | 829.00 shares derived: sum of 2 quarters · filed 2025-02-11 | 12.25K shares derived: sum of 3 quarters · filed 2025-02-11 | 252.49K shares 10-K · filed 2025-02-11 |
| 2022-09-30 | 829.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | 12.25K shares derived: sum of 2 quarters · filed 2022-10-25 | 252.49K shares 10-Q · filed 2022-10-25 | 261.49K shares derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | 11.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-26 | 251.66K shares 10-Q · filed 2022-07-26 | 260.66K shares derived: sum of 3 quarters · filed 2024-02-13 | 260.66K shares derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | 240.24K shares 10-Q · filed 2022-04-26 | 249.24K shares derived: sum of 2 quarters · filed 2024-02-13 | 249.24K shares derived: sum of 3 quarters · filed 2024-02-13 | 522.83K shares derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | 9.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | 9.00K shares derived: sum of 2 quarters · filed 2024-02-13 | 282.59K shares derived: sum of 3 quarters · filed 2024-02-13 | 282.59K shares 10-K · filed 2024-02-13 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-26 | 273.59K shares derived: sum of 2 quarters · filed 2021-10-26 | 273.59K shares 10-Q · filed 2021-10-26 | 273.59K shares derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | 273.59K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | 273.59K shares 10-Q · filed 2021-07-27 | 273.59K shares derived: sum of 3 quarters · filed 2023-02-14 | 278.39K shares derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-04-27 | 0.00 shares derived: sum of 2 quarters · filed 2023-02-14 | 4.80K shares derived: sum of 3 quarters · filed 2023-02-14 | 27.95K shares derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | 4.80K shares derived: sum of 2 quarters · filed 2023-02-14 | 27.95K shares derived: sum of 3 quarters · filed 2023-02-14 | 227.35K shares 10-K · filed 2023-02-14 |
| 2020-09-30 | 4.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | 27.95K shares derived: sum of 2 quarters · filed 2020-10-27 | 227.35K shares 10-Q · filed 2020-10-27 | 230.37K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | 23.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | 222.55K shares 10-Q · filed 2020-07-28 | 225.57K shares derived: sum of 3 quarters · filed 2022-02-15 | 700.00K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | 199.41K shares 10-Q · filed 2020-04-29 | 202.43K shares derived: sum of 2 quarters · filed 2022-02-15 | 676.86K shares derived: sum of 3 quarters · filed 2022-02-15 | 954.95K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | 3.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 477.45K shares derived: sum of 2 quarters · filed 2022-02-15 | 755.54K shares derived: sum of 3 quarters · filed 2022-02-15 | 859.96K shares 10-K · filed 2022-02-15 |
| 2019-09-30 | 474.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | 752.52K shares derived: sum of 2 quarters · filed 2019-10-29 | 856.94K shares 10-Q · filed 2019-10-29 | 964.44K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | 278.09K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | 382.51K shares 10-Q · filed 2019-07-30 | 490.01K shares derived: sum of 3 quarters · filed 2021-02-16 | 503.43K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | 104.42K shares 10-Q · filed 2019-04-30 | 211.92K shares derived: sum of 2 quarters · filed 2021-02-16 | 225.34K shares derived: sum of 3 quarters · filed 2021-02-16 | 282.22K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | 107.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | 120.92K shares derived: sum of 2 quarters · filed 2021-02-16 | 177.80K shares derived: sum of 3 quarters · filed 2021-02-16 | 584.30K shares 10-K · filed 2021-02-16 |
| 2018-09-30 | 13.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | 70.30K shares derived: sum of 2 quarters · filed 2018-10-30 | 476.80K shares 10-Q · filed 2018-10-30 | 511.80K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | 56.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | 463.38K shares 10-Q · filed 2018-07-31 | 498.38K shares derived: sum of 3 quarters · filed 2020-02-25 | 548.38K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | 406.50K shares 10-Q · filed 2018-05-01 | 441.50K shares derived: sum of 2 quarters · filed 2020-02-25 | 491.50K shares derived: sum of 3 quarters · filed 2020-02-25 | 560.35K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | 35.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 85.00K shares derived: sum of 2 quarters · filed 2020-02-25 | 153.85K shares derived: sum of 3 quarters · filed 2020-02-25 | 853.90K shares 10-K · filed 2020-02-25 |
| 2017-09-30 | 50.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | 118.85K shares derived: sum of 2 quarters · filed 2017-10-31 | 818.90K shares 10-Q · filed 2017-10-31 | |
| 2017-06-30 | 68.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | 768.90K shares 10-Q · filed 2017-08-01 | ||
| 2017-03-31 | 700.05K shares 10-Q · filed 2017-05-02 | |||
| 2016-12-31 | 683.00K shares 10-K · filed 2019-02-26 | |||
| 2015-12-31 | 889.85K shares 10-K · filed 2018-02-27 | |||
| 2014-12-31 | 1.13M shares 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |